Expression status of let-7a and miR-335 among breast tumors in patients with and without germ-line BRCA mutations

Molecular and Cellular Biochemistry

Volumn 395, Issue 1-2, 2014, Pages 77-88

  Erturk, Elif ^a   Cecener, Gulsah ^a   Egeli, Unal ^a   Tunca, Berrin ^a   Tezcan, Gulcin ^a   Gokgoz, Sehsuvar ^a   Tolunay, Sahsine ^a   Tasdelen, Ismet ^a  

^a ULUDAG UNIVERSITY   (Turkey)

Author keywords

BRCA1 2 gene mutations; Breast cancer; Let 7a; MicroRNA; MiR 335

Indexed keywords

MICRORNA; BRCA1 PROTEIN; BRCA1 PROTEIN, HUMAN; BRCA2 PROTEIN; BRCA2 PROTEIN, HUMAN; MIRN335 MICRORNA, HUMAN; MIRNLET7 MICRORNA, HUMAN;

ADULT; AGED; AMINO ACID SUBSTITUTION; ARTICLE; BLOOD SAMPLING; BREAST CANCER; CANCER PROGNOSIS; CANCER RESISTANCE; CANCER SUSCEPTIBILITY; CANCER TISSUE; CONTROLLED STUDY; FAMILIAL CANCER; FEMALE; FRAMESHIFT MUTATION; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC SUSCEPTIBILITY; GERMLINE MUTATION; HUMAN; HUMAN TISSUE; LET 7A GENE; MAJOR CLINICAL STUDY; MISSENSE MUTATION; MUTATIONAL ANALYSIS; ONCOGENE; ONSET AGE; REAL TIME POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; TUMOR SUPPRESSOR GENE; BREAST TUMOR; DOWN REGULATION; GENE EXPRESSION REGULATION; GENETICS; MIDDLE AGED; PATHOLOGY; PROGNOSIS; YOUNG ADULT;

ADULT; AGED; BRCA1 PROTEIN; BRCA2 PROTEIN; BREAST NEOPLASMS; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GERM-LINE MUTATION; HUMANS; MICRORNAS; MIDDLE AGED; PROGNOSIS; YOUNG ADULT;

EID: 84906256891     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-014-2113-4     Document Type: Article

References (55)

1. Egeli U, Cecener G, Tunca B, Tasdelen I (2006) Novel germline BRCA1 and BRCA2 mutations in Turkish women with breast and/or ovarian cancer and their relatives. Cancer Invest 24:484-491 (Pubitemid 44591877)
2. Schnitt SJ (2010) Classification and prognosis of invasive breast cancer: from morphology to molecular taxonomy. Mod Pathol 2:60-64
3. Ozmen V, Ozcinar B, Karanlik H, Cabioglu N, Tukenmez M, Disci R, Ozmen T, Igci A, Muslumanoglu M, Kecer M, Soran A (2009) Breast cancer risk factors in Turkish women - a university hospital based nested case control study. World J Surg Oncol 37:1-8
4. Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74-108 (Pubitemid 40372904)
5. Kim Y, Choi JY, Lee KM, Park SK, Ahn SH, Noh DY, Hong YC, Kang D, Yoo KY (2007) Dose dependent protective effect of breast feeding against breast cancer among ever lactated women in Korea. Eur J Cancer Prev 16:124-129
6. Tuncer M (2008) Significance of cancer in Turkey, the burden of disease and cancer control policies. In: Tuncer M (ed) Cancer control in Turkey, vol 74. Ankara, Onur Press, Health Ministry Publication, pp 5-9
7. Szabo CI, King MC (1997) Population genetics of BRCA1 and BRCA2. Am J Hum Genet 60:1013-1020 (Pubitemid 27194085)
8. Ferla R, Calò V (2007) Founder mutations in BRCA1 and BRCA2 genes. Ann Oncol 18:93-98
9. Kenemans P, Verstraeten RA, Verheijen RHM (2004) Oncogenic pathways in hereditary and sporadic breast cancer. Maturitas 49:34-43 (Pubitemid 39209369)
10. Imyanitov EN, Moiseyenko VM (2011) Drug therapy for hereditary cancers. Hered Cancer Clin Pract 6:5-9
11. Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S, Noch E, Aldler H, Rattan S, Keating M, Rai K, Rassenti L, Kipps T, Negrini M, Bullrich F, Croce CM (2002) Frequent deletions and down regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci 99:15524-15529 (Pubitemid 35403967)
12. Calin GA, Sevignani C, Dumitru CD, Hyslop T, Noch E, Yendamuri S, Shimizu M, Rattan S, Bullrich F, Negrini M, Croce CM (2004) Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci 101:2999-3004 (Pubitemid 38327724)
13. He L, Thomson JM, Hemann MT, Hernando-Monge E, Mu D, Goodson S, Powers S, Cordon-Cardo C, Lowe SW, Hannon GJ, Hammond SM (2005) A microRNA polycistron as a potential human oncogene. Nature 435:828-833 (Pubitemid 40839734)
14. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA, Downing JR, Jacks T, Horvitz HR, Golub TR (2005) MicroRNA expression profiles classify human cancers. Nature 435:834-838 (Pubitemid 40839735)
15. Calin GA, Croce C (2006) MicroRNA signatures in human cancers. Nat Rev Cancer 6:857-866 (Pubitemid 44629897)
16. Esquela-Kerscher A, Slack FJ (2006) OncomiRs - microRNAs with a role in cancer. Nat Rev Cancer 6:259-269
17. Garzon R, Fabbri M, Cimmino A, Calin GA, Croce CM (2006) MicroRNA expression and function in cancer. Trends Mol Med 12:580-587 (Pubitemid 44780201)
18. Filipowicz W, Bhattacharyya SN, Sonenberg N (2008) Mechanisms of posttranscriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet 9:102-114
19. Iorio M, Casalini P, Tagliabue E, Ménard S, Croce C (2008) MicroRNA profiling as a tool to understand prognosis, therapy response and resistance in breast cancer. Eur J Cancer 44:2753-2759
20. Ng EK, Wong CL, Ma ES, Kwong A (2009) MicroRNAs as new players for diagnosis, prognosis, and therapeutic targets in breast cancer. J Oncol 305420:1-6
21. Visone R, Croce C (2009) MicroRNAs and cancer. Am J Pathol 174:1131-1138
22. Pinto R, Pilato B, Ottini L, Lambo R, Simone G, Paradiso A, Tommasi S (2013) Different methylation and microRNA expression pattern in male and female familial breast cancer. J Cell Physiol 228:1264-1269
23. Findlay VJ (2010) MicroRNAs and breast cancer. Open Cancer J 3:55-61
24. Brewster BL, Rossiello F, French JD, Edwards SL, Wong M, Wronski A, Whiley P, Waddell N, Chen X, Bove B, kConFab, Hopper JL, John EM, Andrulis I, Daly M, Volorio S, Bernard L, Peissel B, Manoukian S, Barile M, Pizzamiglio S, Verderio P, Spurdle AB, Radice P, Godwin AK, Southey MC, Brown MA, Peterlongo P (2012) Identification of fifteen novel germline variants in the BRCA1 30 UTR reveals a variant in a breast cancer case that introduces a functional miR-103 target site. Hum Mutat 33:1665-1675
25. Lheureux S, Lambert B, Krieger S, Legros A, Vaur D, Denoyelle C, Berthet P, Poulain L, Hardouin A (2011) Two novel variants in the 3′UTR of the BRCA1 gene in familial breast and/or ovarian cancer. Breast Cancer Res Treat 125:885-891
26. Kontorovich T, Levy A, Korostishevsky M, Nir U, Friedman E (2010) Single nucleotide polymorphisms in miRNA binding sites and miRNA genes as breast/ovarian cancer risk modifiers in Jewish high-risk women. Int J Cancer 127:589-597
27. Shen J, Ambrosone CB, Zhao H (2009) Novel genetic variants in microRNA genes and familial breast cancer. Int J Cancer 124:1178-1182
28. Barh D, Malhotra R, Ravi B, Sindhurani P (2010) MicroRNA let-7: an emerging nextgeneration cancer therapeutic. Curr Oncol 17:70-80
29. O'Day E, Lal A (2010) MicroRNAs and their target gene networks in breast cancer. Breast Cancer Res 12:201-211
30. Cecener G, Egeli U, Tunca B, Erturk E, Ak S, Gokgoz S, Tasdelen I, Tezcan G, Demirdogen E, Bayrom N, Avci N, Evrensel T (2014) BRCA1/2 Germline mutations and their clinical importance in Turkish breast cancer patients. Cancer Invest 1-13. doi:10.3109/07357907.2014.919302
31. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Δ Δ C(T)) method. Methods 25:402-408 (Pubitemid 34164012)
32. Calin GA, Ferracin M, Cimmino A, Di Leva G, Shimizu M, Wojcik SE, Iorio MV, Visone R, Sever NI, Fabbri M, Iuliano R, Palumbo T, Pichiorri F, Roldo C, Garzon R, Sevignani C, Rassenti L, Alder H, Volinia S, Liu CG, Kipps TJ, Negrini M, Croce CM (2005) A microRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med 353:1793-1801 (Pubitemid 41549891)
33. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M, Prueitt RL, Yanaihara N, Lanza G, Scarpa A, Vecchione A, Negrini M, Harris CC, Croce CM (2006) A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci 103:2257-2261 (Pubitemid 43271657)
34. Yanaihara N, Caplen N, Bowman E, Seike M, Kumamoto K, Yi M, Stephens RM, Okamoto A, Yokota J, Tanaka T, Calin GA, Liu CG, Croce CM, Harris CC (2006) Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 9:189-198 (Pubitemid 43357945)
35. Barbarotto E, Schmittgen DT, Calin G (2008) MicroRNAs and cancer: profile, profile, profile. Int J Cancer 122:969-977 (Pubitemid 351213993)
36. Lee CH, Subramanian S, Beck AH, Espinosa I, Senz J, Zhu SX, Huntsman D, van de Rijn M, Gilks CB (2009) MicroRNA profiling of BRCA1/2 mutation-carrying and non-mutation-carrying high-grade serous carcinomas of ovary. PLoS One 4:7314-7325
37. Zhang H, Li Y, Lai M (2010) The microRNA network and tumor metastasis. Oncogene 29:937-948
38. Zhao Y, Deng C, Lu W, Xiao J, Ma D, Guo M, Recker RR, Gatalica Z, Wang Z, Xiao GG (2011) Let-7 microRNAs induce tamoxifen sensitivity by down regulation of estrogen receptor alpha signaling in breast cancer. Mol Med 17:1233-1241
39. Kim SJ, Shin JY, Lee KD, Bae YK, Sung KW, Nam SJ, Chun KH (2012) MicroRNA let-7a suppresses breast cancer cell migration and invasion through down regulation of C-C chemokine receptor type 7. Breast Cancer Res 18:14-26
40. Takamizawa J, Konishi H, Yanagisawa K, Tomida S, Osada H, Endoh H, Harano T, Yatabe Y, Nagino M, Nimura Y, Mitsudomi T, Takahashi T (2004) Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened post-operative survival. Cancer Res 64:3753-3756 (Pubitemid 38697282)
41. Johnson CD, Esquela-Kerscher A, Stefani G, Byrom M, Kelnar K, Ovcharenko D, Wilson M, Wang X, Shelton J, Shingara J, Chin L, Brown D, Slack FJ (2007) The let-7 microRNA represses cell proliferation pathways in human cells. Cancer Res 67:7713-7722 (Pubitemid 47281364)
42. Marson A, Levine SS, Cole MF, Frampton GM, Brambrink T, Johnstone S, Guenther MG, Johnston WK, Wernig M, Newman J, Calabrese JM, Dennis LM, Volkert TL, Gupta S, Love J, Hannett N, Sharp PA, Bartel DP, Jaenisch R, Young RA (2008) Connecting microRNA genes to the core transcriptional regulatory circuitry of embryonic stem cells. Cell 134:521-533
43. Yu F, Yao H, Zhu P, Zhang X, Pan Q, Gong C, Huang Y, Hu X, Su F, Lieberman J, Song E (2007) Let-7 regulates self renewal and tumorigenicity of breast cancer cells. Cell 131:1109-1123 (Pubitemid 350235025)
44. Kubista M, Rosner M, Kubista E, Bernaschek G, Hengstschlager M (2002) Brca1 regulates in vitro differentiation of mammary epithelial cells. Oncogene 21:4747-4756 (Pubitemid 34879450)
45. Furuta S, Jiang X, Gu B, Cheng E, Chen PL, Lee WH (2005) Depletion of BRCA1 impairs differentiation but enhances proliferation of mammary epithelial cells. Proc Natl Acad Sci USA 102:9176-9181 (Pubitemid 40923537)
46. Bane A, Viloria-Petit A, Pinnaduwage D, Mulligan AM, O'Malley FP, Andrulis IL (2013) Clinical - pathologic significance of cancer stem cell marker expression in familial breast cancers. Breast Cancer Res Treat 140:195-205
47. Heyn H, Engelmann M, Schreek S, Ahrens P, Lehmann U, Kreipe H, Schlegelberger B, Beger C (2011) MicroRNA miR-335 is crucial for the BRCA1 regulatory cascade in breast cancer development. Int J Cancer 129:2797-2806
48. Hafez MM, Hassan ZK, Zekri AR, Gaber AA, Al Rejaie SS, Sayed-Ahmed MM, Al Shabanah O (2012) MicroRNAs and metastasis-related gene expression in Egyptian breast cancer patients. Asian Pac J Cancer Prev 13:591-598
49. Tavazoie SF, Alarcón C, Oskarsson T, Padua D, Wang Q, Bos PD, Gerald WL, Massagué J (2008) Endogenous human microRNAs that suppress breast cancer metastasis. Nature 451:147-152
50. Sorrentino A, Liu C, Addario A, Peschle C, Scambia G, Ferlini C (2008) Role of microRNAs in drug-resistant ovarian cancer cells. Gynecol Oncol 111:478-486
51. Verghese ET, Hanby AM, Speirs V, Hughes TA (2008) Small is beautiful: microRNAs and breast cancer - where are we now? J Pathol 215:214-221 (Pubitemid 351956702)
52. Shi M, Liu D, Duan H, Shen B, Guo N (2010) Metastasis-related miRNAs, active players in breast cancer invasion and metastasis. Cancer Metastasis Rev 29:785-799
53. Inwald EC, Klinkhammer-Schalke M, Hofstädter F, Zeman F, Koller M, Gerstenhauer M, Ortmann O (2013) Ki-67 is a prognostic parameter in breast cancer patients: results of a large population-based cohort of a cancer registry. Breast Cancer Res Treat 139:539-552
54. Polley MY, Leung SC, McShane LM, Gao D, Hugh JC, Mastropasqua MG, Viale G, Zabaglo LA, Penault-Llorca F, Bartlett JM, Gown AM, Symmans WF, Piper T, Mehl E, Enos RA, Hayes DF, Dowsett M, Nielsen TO (2013) On behalf of the International Ki67 in Breast Cancer Working Group of the Breast International Group and North American Breast Cancer Group: an International Ki67 Reproducibility Study. J Natl Cancer Inst 105:1897-1906
55. Zhao JJ, Lin J, Yang H, Kong W, He L, Ma X, Coppola D, Cheng JQ (2008) MicroRNA-221/222 negatively regulates estrogen receptor alpha and is associated with tamoxifen resistance in breast cancer. J Biol Chem 283:31079-31086